Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Endothelin antagonists merit evaluation in vasoconstrictive diseases; leaves open clinical adoption pending randomized trials.
Parris et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: